Thus, isoform-selective PI3K inhibitors impeded glioblastoma cell migration through blockade of FAK activation, and reduced FAK or zyxin activation contributed to the synergistic inhibitory effects on glioblastoma cell migration. The gene discussed is PTK2; the disease is glioblastoma.